GPx4 in the ferroptosis regulatory pathway: (a) GPx4 catalytic cycle representation
Role of GPx4 in the ferroptosis regulatory pathway: (a) GPx4 catalytic cycle representation. Under the reduction of lipid hydroperoxides (PLOOH) into their respective alcohols (PLOH), catalyzed by GPx4, GPx4 selenol (GPx4-SeH) is oxidized into selenic acid (GPx4-SeOH). Selenic acid is reduced to its active form, selenol, by a two-step reaction with GSH: The first GSH reacts with selenic acid to form a selenium–glutathione intermediate (GPx4-Se-SG), which is reduced by the second GSH to selenol. (b) Regulation of ferroptosis by GPx4. The conversion of polyunsaturated fatty acids (PUFAs) of phospholipids to peroxide PUFAs represents the initiation step to drive ferroptotic cell death. The phospholipid hydroperoxides (PE-OOH) are formed via non-enzymatic and enzymatic lipid peroxidation. The increased cytosolic labile iron pool (LIP) activates Fenton reactions and generates •OH radicals, which initiate non-enzymatic lipid peroxidation with the formation of PE-OOH, and their levels can be raised by 15-lipoxygenase (LOX) activity. GPx4 catalyzes the reduction of toxic PE-OOH into nontoxic alcohol, ultimately inhibiting ferroptosis. The amino acid antiporter system xc- (composed of SLC3A2 and SLC7A11 subunits) mediates the exchange of intracellular glutamate and extracellular cystine, which is converted into cysteine, contributing to GSH synthesis. Inhibition of the key enzyme of GSH synthesis—γGCL (buthionine sulfoximine, BSO)—and SLC7A11 (erastin, sulfasalazine, sorafenib) leads to the activation of ferroptosis through GSH depletion. A selenocysteine residue is added to the catalytic center of GPx4 with the use of isopentenyl pyrophosphate (IPP), leading to GPx4 activation and ferroptosis inhibition. IPP is generated via the mevalonate pathway: acetyl-CoA is converted to 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA). HMG-CoA is reduced by 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) to mevalonate, which, in turn, is converted to IPP. IPP also generates coenzymeQ10 (ubiquinone, CoQ10), which is reduced to ubiquinol by ferroptosis-suppressor-protein 1 (FSP1), blocking lipid peroxidation. The ferroptotic inducer FIN56 works through a dual mechanism of depleting GPX4 protein and CoQ10 levels